TNXP Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.

$0.38
As of 12/01/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/03/2012
Outstanding shares:  57,536,293
Average volume:  1,575,592
Market cap:   $22,214,763
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BM9PL28
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.03
PS ratio:   0.00
Return on equity:   -47.15%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy